Clinical Trials
26 trialsClinical Utility for Ion Endoluminal System
Intuitive Surgical
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
Azienda Sanitaria-Universitaria Integrata di Udine
ILST
The University of Queensland
Holo-lungs
European Institute of Oncology
3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial
Sichuan Cancer Hospital and Research Institute
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Breath Analysis by Ion Mobility Spectrometry
Lung Clinic Hemer
To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery
Centre Hospitalier Universitaire de Tivoli
The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)
Lifesemantics Corp.
A Clinical Study of LUNG-CT CAD Decision Support
TaiHao Medical Inc.
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications
ASP Health
VATS
Ain Shams University
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
COVID19REHAB
Centro Universitário de Anapolis
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma
Sichuan Cancer Hospital and Research Institute
EPIC
University of Turin, Italy
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Shanghai Gebaide Biotechnology Co., Ltd.
VOCs
Chinese PLA General Hospital
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Wenzhou Medical University
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Université de Sherbrooke
Advance Care Planning: A Way to Improve End-of-life Care Life Care
University of Aarhus